Posted by Michael Wonder on 12 May 2023
FDA approves novel drug to treat moderate to severe hot flashes caused by menopause
12 May 2023 - Today, the US FDA approved Veozah (fezolinetant), an oral medication for the treatment of moderate to severe vasomotor symptoms, or hot flashes, caused by menopause.
Veozah is the first neurokinin 3 receptor antagonist approved by the FDA to treat moderate to severe hot flashes from menopause.
